Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

13.0K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.0K
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

233
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
233
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

583
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
583
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

3.1K
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HEroBM: A deep equivariant graph neural network for high-fidelity backmapping from coarse-grained to all-atom structures.

The Journal of chemical physics·2025
Same author

PLUMED Tutorials: A collaborative, community-driven learning ecosystem.

The Journal of chemical physics·2025
Same author

Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery.

Nature reviews. Drug discovery·2025
Same author

Correction to "Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders".

ACS omega·2023
Same author

Conformational plasticity and allosteric communication networks explain Shelterin protein TPP1 binding to human telomerase.

Communications chemistry·2023
Same author

Structural basis of dimerization of chemokine receptors CCR5 and CXCR4.

Nature communications·2023

Related Experiment Video

Updated: Jul 17, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K

Perspectives on Ligand/Protein Binding Kinetics Simulations: Force Fields, Machine Learning, Sampling, and

Paolo Conflitti1, Stefano Raniolo1, Vittorio Limongelli1,2

  • 1Faculty of Biomedical Sciences, Euler Institute, Universitá della Svizzera italiana (USI), 6900 Lugano, Switzerland.

Journal of Chemical Theory and Computation
|September 1, 2023
PubMed
Summary

Computational drug discovery accelerates preclinical research by filtering drug candidates. This review explores ligand/protein binding kinetics, highlighting advanced techniques and future directions for more accurate drug design.

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

322
Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry
07:33

Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry

Published on: October 15, 2018

14.3K

Related Experiment Videos

Last Updated: Jul 17, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

322
Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry
07:33

Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry

Published on: October 15, 2018

14.3K

Area of Science:

  • Computational chemistry
  • Pharmacology
  • Biophysics

Background:

  • Computational drug discovery aids in identifying active compounds, reducing costs and time.
  • Historically, focus has been on high-affinity ligands for stable drug-target complexes.
  • Emerging research links in vivo drug efficacy to binding kinetics, necessitating kinetic simulations.

Purpose of the Study:

  • To review the current state of ligand/protein binding kinetic simulation techniques in drug discovery.
  • To evaluate the limitations of existing methodologies.
  • To propose solutions for developing more accurate kinetic models.

Main Methods:

  • Review of popular and advanced ligand/protein binding kinetic simulation techniques.
  • Analysis of current challenges in computational drug discovery.
  • Discussion of potential solutions and future research directions.

Main Results:

  • Identified key areas for improvement in kinetic modeling: parametrization, force fields, transition states, sampling, and algorithm performance.
  • Highlighted the need for a paradigm shift in current methodologies.
  • Emphasized user-friendliness and data openness as crucial for progress.

Conclusions:

  • Ligand/protein binding kinetics are crucial for predicting in vivo drug efficacy.
  • Significant advancements are needed in computational methodologies for accurate kinetic modeling.
  • Future efforts should focus on improving parametrization, sampling, and algorithm development for enhanced drug discovery.